Source: Annual Congress 2009 - Severe asthma and its treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Mineev, L. Sorokina, V. Berestovskaya, M. Nyoma, V. Trofimov (Saint-Petersburg, Russian Federation). Leptin as a specific marker of risk factors in severe bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 1861

Member's Comments

BRUNO Andreina - 14.09.2009 14:26
Categorie of asthmatic patients
Interesting work. Which kind of severe asthma affected the patients enrolled? Neutrofilic or eosinophilic asthma?

Related content which might interest you: Severe bronchial asthma: risk factors Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 406s Year: 2002 Increased bronchial hyperreactivity (BHR) in sarcoidosis patients maybe a risk factor for progression of the disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 45s Year: 2005 Allergic rhinitis co-morbidity as risk factor on lung function parameters recovery after asthma exacerbation Source: International Congress 2019 – Epidemiology of childhood respiratory diseases Year: 2019 Chronic bronchitis, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases. Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 The risk factors contributing asthma development in children Source: Eur Respir J 2002; 20: Suppl. 38, 144s Year: 2002 Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children Source: Eur Respir J 2001; 18: Suppl. 33, 452s Year: 2001 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Prevalence and risk factors of fixed airway obstruction in children with asthma Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018 Airway hyperresponsiveness and smoking, but not atopy, are associated with moderate and severe-persistent respiratory disease: analysis of a longitudinal birth cohort Source: Annual Congress 2005 - Highlights of asthma epidemiology Year: 2005 Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study Source: Eur Respir J 2009; 33: 218-219 Year: 2009 Interleukin-10 polymorphisms influence the neonatal immune response and may be a risk factor for childhood allergic disease and wheeze Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 Risk factors for severe asthma among adults with asthma Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020 Exacerbations in severe persistent asthma - impact of risk factors control Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Increased serum IL-17 is an independent risk factor for severe asthma Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008 The risk of cardiovascular disease associated with asthma may be mediated by short-acting β2-agonists Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008 Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019